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Abstract  29 
New Zealand blackcurrant (NZBC) contains anthocyanins, known to moderate blood flow and 30 
display anti-inflammatory properties that may improve recovery from exercise-induced muscle 31 
damage (EIMD). We examined whether NZBC extract supplementation enhances recovery 32 
from EIMD after a half-marathon race. Following a randomized, double-blind, independent 33 
groups design, 20 (8 women) recreational runners (age 30 ± 6 years, height 1.73 ± 0.74 m, 34 
body mass 68.5 ± 7.8 kg, half-marathon finishing time 1:56:33 ± 0:18:08 h:min:s) ingested 35 
either two 300 mg·day-1 capsules of NZBC extract (CurraNZ™) or a visually matched placebo 36 
(PLA), for 7-days prior to and 2-days following a half-marathon. Countermovement jump 37 
(CMJ) performance variables, urine interleukin-6 (IL-6), perceived muscle soreness and 38 
fatigue were measured pre-, post-, and at 24 h and 48 h after the half-marathon and analysed 39 
using a mixed linear model with statistical significance set a priori at P<0.05. The CMJ 40 
performance variables were reduced immediately post-half-marathon (P<0.05) with all 41 
returning to pre half-marathon by 48 h levels except concentric and eccentric peak force and 42 
eccentric duration, with no difference in response between groups (P>0.05). Urine IL-6 43 
increased 48 h post-half-marathon in the NZBC group only (P<0.01) and remained unchanged 44 
compared to pre half-marathon levels in PLA group (P>0.05). Perceived muscle soreness and 45 
fatigue increased immediately post-half-marathon (P<0.01) and returned to pre half-marathon 46 
by 48 h, with no difference between groups (P>0.05). Supplementation with NZBC extract had 47 
no effect on the recovery of countermovement jump variables and perceptions of muscle 48 
soreness or fatigue following a half-marathon in recreational runners.  49 
 50 
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Introduction  57 
Exercise-induced muscle damage (EIMD) occurs following exercise that involves eccentric 58 
contractions (Paulsen et al. 2012). A biphasic response to EIMD is typically observed, where 59 
initially metabolic and mechanical disruptions are followed by a secondary phase initiated by 60 
a disruption in intracellular Ca2+ homeostasis (Howatson & van Someren. 2008). Half-61 
marathons have been shown to cause EIMD (Duthie et al. 1990; Withee et al. 2017). The 62 
magnitude of EIMD can be assessed through direct measures of structural damage and force 63 
deficits (Warren et al. 1999; Clarkson & Hubal. 2002) and via indirect markers measured 64 
systemically in plasma such as creatine kinase (CK) and inflammatory cytokines (e.g. 65 
interleukin-6 (IL-6)) and muscle soreness (Hydahl & Hubal. 2014; Clarkson & Hubal. 2002).  66 
 67 
Recently, foods and supplements that are rich in polyphenols such as berries and fruits have 68 
been shown to enhance exercise performance and recovery (for a review see Cook & Willems. 69 
2018). Montmorency tart cherry juice (MCJ) has been shown to enhance recovery of muscle 70 
function and reduce inflammation and lipid peroxidation following a marathon race (Howatson 71 
et al. 2009). However, beetroot juice supplementation did not affect recovery following a 72 
marathon race (Clifford et al. 2016). The difference may be related to the profile of the 73 
polyphenolic compounds, e.g. the anthocyanins. Although the precise mechanisms are not 74 
clear, it has been speculated that anthocyanins may exert their recovery benefits by 75 
upregulating endothelial nitric oxide synthase (eNOS) activity, thus improving blood flow to the 76 
affected tissues (Cook & Willems, 2018). New Zealand blackcurrant (NZBC) is unique due to 77 
its high anthocyanin content and has been shown to enhance exercise performance (for a 78 
review see Cook & Willems, 2018) and recovery from EIMD (Coelho et al. 2017) in laboratory 79 
settings. The effects of NZBC extract on recovery following more ecologically valid events in 80 
the field, such as a half-marathon race, are not known.  81 
 82 
The aim of this study was to examine the effect of NZBC extract supplementation taken before 83 
and following running a half-marathon race on markers of EIMD. It was hypothesized that 84 
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NZBC extract, when compared to placebo (PLA), would facilitate recovery, by accelerating the 85 
return of muscle function, reducing muscle soreness and fatigue, and inhibiting the exercise-86 
induced inflammatory cascade.  87 
 88 
Materials and methods  89 
Participants 90 
Twelve healthy men and eight healthy women (Table 1) who were runners taking part in the 91 
2018 Chichester Half-Marathon, Chichester, UK volunteered to participate in the study. Based 92 
on a similar previous study focusing on recovery with a polyphenol-rich supplement following 93 
a running event (Clifford et al. 2016), established on Counter Movement Jump (CMJ) height 94 
we calculated (G*Power; Faul et al. 2007) that at 80% power, and an α of 0.05, at least eight 95 
volunteers were required to detect a group difference of 5% (using change from pre-half 96 
marathon data) (3.5% SD) at any time points post the half-marathon event. Participants 97 
completed a health history questionnaire, were non-smokers, had no known food allergies 98 
and were not taking anti-inflammatory therapies. Females completed a menstrual cycle 99 
questionnaire (Köhne et al. 2016). Participants abstained from strenuous exercise and alcohol 100 
for 48 h prior, and caffeine-containing products on the day of the half-marathon. Participants 101 
were also asked to avoid all additional means that could affect recovery and adhere to their 102 
normal activity schedule. The study was approved by the University of Chichester Research 103 
Ethics Committee with protocols and procedures conforming to the 2013 Declaration of 104 
Helsinki.  105 
 106 
***Insert Table 1 near here*** 107 
 108 
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Experimental design 109 
The study followed a double-blind, placebo-controlled, randomised, independent-groups study 110 
design. Groups were matched according to predicted half-marathon finish times by pairing 111 
participants with equivalent times (Howatson et al. 2009; Clifford et al. 2016). Blinding of the 112 
placebo and supplement was carried out by an independent researcher who had no 113 
involvement with this investigation. Packets were made up with visually identical NZBC and 114 
placebo capsules for each participant and labelled with a random letter. Each participant in a 115 
matched pair was randomly assigned to one of the letters and provided with that packet of 116 
capsules. The blinding codes were revealed following data analysis. The participants 117 
completed one familiarisation visit, and four experimental visits pre- and immediately post-118 
half-marathon (in the race holding area), 24 and 48 h (laboratory; Figure 1). For the 119 
familiarisation visit, participants were briefed on the study, explained all the procedures and 120 
had their height and body mass recorded. Countermovement jumps (CMJ), visual analogue 121 
scales (VAS) for muscle soreness and fatigue and a urine sample were completed in this order 122 
during each experimental visit. Heart rate was collected during the half-marathon (Polar Team 123 
2, Polar Electro Ltd, UK) and race distance confirmed using GPS (Polar M430 GPS, Polar 124 
Electro Ltd, UK).  125 
 126 
***Insert Figure 1 near here*** 127 
 128 
Half-marathon 129 
The half-marathon took place on 19th October 2018 in Chichester (West Sussex, UK). The 130 
course was mostly flat, across a mix of concrete terrain, grass and chalk. However, mile 4 to 131 
8 consisted of a steep incline and decline (total route ascent: 239 m; total route descent: 232 132 
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m). At the start of race at 9:00, the air temperature was 8oC, humidity 81%, barometric 133 
pressure 1023 hPa, and air speed 10 mph. It remained dry and mostly overcast with 134 
intermittent sunny spells for the duration of the race.  135 
 136 
Supplementation protocol 137 
Participants ingested two capsules of NZBC extract (2 x 300 mg CurraNZTM) each containing 138 
105 mg of anthocyanins (CurraNZTM, Health Currancy Ltd, Surrey, United Kingdom) or two 139 
capsules of identical looking placebo capsules (2 x 300 mg microcrystalline cellulose M102; 140 
CurraNZTM, Health Currancy Ltd, Surrey, United Kingdom) with breakfast every morning for 7-141 
days and 2-days following the half-marathon. On the morning of the half-marathon, 142 
participants consumed their supplement 2 h prior to starting the race. This supplementation 143 
regime was based on previous work where anthocyanins peak in systemic circulation ~2 h 144 
after ingestion (Matsumoto et al. 2005). Full compliance with intake was achieved. Blinding 145 
was not broken until after analysis was completed and a follow-up questionnaire revealed 40% 146 
of participants accurately guessed which supplementation they received.  147 
 148 
Dietary intake 149 
For ecological validity, participants maintained their habitual diet prior to and post- the half-150 
marathon (Bowtell & Kelly. 2019) and recorded their 72 h dietary intake in food diaries which 151 
were analysed (Nutritics Ltd, Dublin, Ireland) for carbohydrate, fat and protein, and total 152 
energy intake. The habitual anthocyanin food frequency questionnaire recorded the amount 153 
and frequency of anthocyanin containing foods eaten within the last three months from the 154 
Phenol Explorer database (Neveu et al. 2010). The intake of anthocyanin was calculated as 155 
the sum of the consumption frequency of each anthocyanin containing food, multiplied by the 156 
content of the anthocyanin content for the portion sizes.   157 
 158 
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Indices of muscle function 159 
Countermovement jumps (CMJ) were performed on a force plate (PASPORT force plate, PS-160 
2141, PASCO Scientific, California, USA) sampling at 1000 Hz (Lake et al. 2018). Participants 161 
were instructed to jump as high and as fast as possible, without specific information on squat 162 
depth to avoid altering natural jump patterns (Jidovtseff et al. 2014). Three maximal efforts 163 
were performed, separated by 30 seconds of passive (standing) recovery. Outcome variables 164 
jump height (JH), reactive strength index modified (RSImod), time to take-off, concentric 165 
phase average peak force, net impulse, power, duration and eccentric phase average peak 166 
force, net impulse, displacement (braking phase) and duration are reported (Gathercole et al. 167 
2015). The neuromuscular variables are expressed relative to body mass and outcome 168 
variables JH and RSImod are expressed as a percentage change from pre-half marathon to 169 
account for inter-individual variability. The coefficient of variation for the outcome variables, 170 
JH, RSImod and time to take off was 6, 9 and 6 %, respectively.  171 
 172 
Muscle soreness and fatigue  173 
Whilst in a 90o degree squat position, participants rated their self-perceived muscle soreness 174 
and fatigue were using a 0-10 VAS, where 0 represented no soreness and 10 represented 175 
extreme soreness and 0 represented no fatigue and 10 represented extreme fatigue, 176 
respectively (Jakeman et al. 2017).  177 
 178 
Urine sampling, handling and biochemical analysis 179 
Second evacuation, mid-stream urine samples were collected into 50-mL Falcon® conical 180 
tubes. At all four time points (pre, post, 24 h post and 48 h post), urine was collected and kept 181 
on ice for no more than 2 h prior to being centrifuged at 1000 g for 10 minutes. The urine was 182 
subsequently stored in 2-mL aliquots at -80 oC and thawed on the morning of the analysis. 183 
Urinary IL-6 concentration was determined in duplicate using a quantitative sandwich enzyme 184 
immunoassay ELISA technique (Quantikine, R&D Systems Europe Ltd., Abingdon, UK). 185 
Normal reference ranges for this assay are reported at < 3 pg/mL. The urine intra- and inter-186 
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assay precision determined by CV was 4 %. Urinary cytokine levels were expressed as ratios 187 
of IL-6 to creatinine (pg/mg creatinine) to avoid dilution effects, to be able to compare results 188 
from different participants, and to standardize the samples in light of differences in post-race 189 
hydration status. Urine creatinine was measured using a colorimetric assay (CR510, Randox, 190 
County Antrim, Northern Ireland).  191 
 192 
Data analysis 193 
Statistical analyses were completed using GraphPad Prism V8 (Graphpad software, San 194 
Diego, California). Dependent variables (CMJ, VAS and IL-6 analyses) were analysed using 195 
a mixed linear model with two independent group levels (NZBC vs. PLA) and four repeated 196 
measures time points (pre, post, 24 and 48 h post). The Shapiro-Wilks test was used to check 197 
homogeneity of variance for all variables and any violations of the assumption were corrected 198 
using the Greenhouse-Geisser adjustment. Significant main effects or interactions were 199 
assessed using Bonferroni adjustment post hoc analysis. The alpha level for statistical 200 
significance was set at 0.05 a priori. All data are reported as mean ± SD for n = 10 for each 201 
group, unless otherwise stated.  202 
 203 
Results 204 
Half-marathon finish times did not differ between groups (P=0.67). Average energy intake (KJ) 205 
in the day before the half-marathon until the cessation of the study did not differ between 206 
groups (P=0.90) nor did the proportions coming from carbohydrate (P=0.51), protein (P=0.36) 207 
or fat (P=0.63). Habitual anthocyanin intake did not differ between groups (P=0.99) (Table 2).  208 
 209 
***Insert Table 2 near here*** 210 
 211 
Indices of muscle function  212 
Countermovement jump (CMJ) outcome variables (JH and RSImod) and neuromuscular 213 
variables (concentric average relative peak force, concentric net impulse, concentric average 214 
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power, eccentric average relative peak force, eccentric net impulse) showed a main effect of 215 
time (P<0.01), indicating muscle damage after the half-marathon (Figures 2a, 2b; Table 3). 216 
Relative to pre-half marathon, JH and RSImod decreased to a similar extent in the NZBC and 217 
PLA groups immediately post half-marathon (91.3 ± 11.5 vs 85.6 ± 19.5 %, respectively) and 218 
had returned to pre half-marathon levels by 24 h (97.2 ± 11.1 vs 101.6 ± 10.7 %, respectively). 219 
Apart from TTT, no group or interaction effects were present at any time point for any of the 220 
CMJ outcome or neuromuscular variables (all P>0.05) (Table 3).  221 
 222 
***Insert Table 3 near here*** 223 
 224 
Muscle soreness and fatigue  225 
Muscle soreness and fatigue both showed a main effect of time (P<0.01 and P<0.01, 226 
respectively) (Figures 3a, 3b). However, no group or interaction effects were present at any 227 
time point for muscle soreness or fatigue (P>0.05).  228 
 229 
Inflammatory cytokine response 230 
At 48 h after the half-marathon, IL-6 urine concentrations corrected to creatinine increased 231 
compared to pre-half marathon levels in the NZBC group only (P<0.01) and remained 232 
unchanged at all time points in the placebo group compared to pre-half marathon levels 233 
(P>0.05). No time or interaction effects were present (P>0.05) (Figure 4).  234 
 235 
***Insert Figure 2a, 2b, 3a, 3b, 4 near here*** 236 
 237 
238 
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Discussion  239 
This is the first study to investigate the effect of NZBC extract supplementation on recovery 240 
from EIMD following a half-marathon running race. However, contrary to our hypothesis, 241 
NZBC extract did not affect the recovery of muscle function, reduce muscle soreness or 242 
attenuate the acute inflammatory response in the 48 h after the half-marathon. 243 
 244 
The reduction in the CMJ variables (concentric phase average peak force, net impulse, 245 
average power and eccentric phase average peak force and average duration) immediately 246 
and in the days after the half-marathon running race demonstrated that the event caused 247 
EIMD. However, the similar response for each condition over time indicates that NZBC extract 248 
did not affect post-race muscle recovery. The lack of observable difference between groups 249 
may be due to the half-marathon race only inducing modest changes in all of the CMJ outcome 250 
and neuromuscular variables. Future research could investigate whether NZBC extract is able 251 
to modulate declines in contractile properties following exercise with a greater effect on EIMD.  252 
 253 
The results of the present study are in contrast to those previous ones where anthocyanin rich 254 
supplements have been provided following running exercise. Howatson et al. (2009) showed 255 
that an MCJ supplement enhanced recovery of muscle function following a marathon and 256 
observed attenuation of biomarkers of inflammation (serum C-reactive protein, CRP; IL-6 and 257 
uric acid) and oxidative stress (thiobarbituric acid reactive species, TBARS) in the 48 h 258 
following the marathon; effects that were associated with an accelerated recovery of muscle 259 
function as determined by maximal voluntary isometric contraction (MVIC). Differences in 260 
findings between the present study and Howatson et al. (2009) may be attributable to the 261 
different anthocyanins in each supplement, the mode of delivery (capsules vs. juice) and the 262 
exercise protocol (half-marathon vs marathon). Supplements were provided before and after 263 
the half-marathon both in in the present study (7-days pre, 2-days post), and by Howatson et 264 
al. (2009) (5-days pre, 3 days post). The NZBC in the present study was provided in capsules 265 
containing 210 mg of anthocyanins per day, and the main anthocyanin was delphinidin-3-266 
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rutinoside (Rothwell et al. 2013). In contrast, MCJ was provided in a juice containing 80 mg of 267 
anthocyanins per day and the main anthocyanin was cyanidin-3-glucosylrutinoside (Howatson 268 
et al. 2009). In vitro models have demonstrated that cyanidin-3-glucoside upregulates eNOS 269 
activity (Edwards et al. 2015). As the main anthocyanin in NZBC is delphinidin-3-rutinoside, it 270 
is possible that the cyanidin-3-glucoside in MCJ is better able to upregulate eNOS activity, 271 
thus influencing blood flow through flow mediated dilation (Cook et al. 2017) during strenuous 272 
exercise and reducing the susceptibility to injury (Jones et al. 2017). Further, polyphenol 273 
scavenging has been purported as a potential mechanism by which, polyphenols could help 274 
support redox status by dampening the oxidative stress response following EIMD (Powers & 275 
Jackson, 2008). However, this notion has recently been debated with polyphenol metabolism 276 
to electrophiles and a cyto-protective endogenous antioxidant response via nuclear factor 277 
erythroid 2-related factor 2 (Nrf-2) signalling having been suggested as a more plausible 278 
mechanism (Owens et al. 2018). 279 
 280 
However, other studies have also reported no benefit from supplementation with nitrate-rich, 281 
beetroot juice (Clifford et al. 2016) and anthocyanin-rich, bilberry juice (Lynn et al. 2018) on 282 
markers of EIMD following marathon and half-marathon running, respectively. Clifford et al. 283 
(2016) observed that beetroot juice supplemented for the 3-days following a marathon, was 284 
unable to attenuate declines in CMJ and MVIC, and elevations in markers of inflammation, 285 
(leucocytes, neutrophils, monocytes, hs-CRP, IL-1ra, IL-2, IL-4, IL-6, IL-8, IL-10,TNF-alpha 286 
and interferon-). On the other hand, Lynn et al (2018) concluded that consumption of bilberry 287 
juice 5-days prior to, on race day, and for 2-days following a half-marathon, evoked moderate 288 
increases in exercise-induced muscle soreness and markers of inflammation (CRP) and 289 
muscle damage (determined by creatine kinase concentrations). Similarly, the lack of benefit 290 
observed may be attributable to the different supplementation strategies used (beetroot juice 291 
3-days following the marathon only vs. bilberry juice 5-days prior to, on race day and 2-days 292 
following the half-marathon), leading to different biological activities of the phytonutrients.  293 
 294 
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Using a different exercise model, Coelho et al. (2017) examined the effect of NZBC extract on 295 
recovery from EIMD induced by 60 maximal eccentric contractions of the biceps brachii in 13 296 
healthy young women. No effects on muscle function and plasma IL-6 were reported but 297 
muscle soreness and serum CK were attenuated in the recovery period with NZBC. Compared 298 
to the present study, differences in exercise protocol (half-marathon vs. repeated isolated 299 
forearm flexor exercise), techniques used to quantify EIMD (CMJ vs. MVIC) and participant 300 
characteristics (mixed men and women vs. women only), between the present study and 301 
Coelho et al. (2017) are all factors that could provide a potential explanation for these 302 
equivocal findings.  303 
 304 
Urinary IL-6 has previously been observed to increase following long distance running events 305 
(Sugama et al. 2013; Mrakic-Sposta et al. 2015). However, there was no increase in IL-6 306 
immediately post and 24 after the half-marathon for either PLA or NZBC (Figure 4). Large 307 
inter-individual variability was present due to four participant’s data skewing the NZBC group 308 
average. These data suggest that IL-6 is unlikely to have significant role in the secondary 309 
damage process in the days after a half-marathon in recreational runners. The increase in 310 
urine IL-6 observed at 48 h in the NZBC only could be indicative of the known anti-311 
inflammatory role of the cytokine. However, this is purely speculative without a broader range 312 
of biomarkers indicative of pro- and anti-inflammation and oxidative stress response to 313 
compare with (Owens et al. 2018).  314 
 315 
A limitation of the present study was that participants were not provided with standardised 316 
meals prior to and immediately following the half-marathon event. As the participants 317 
appeared to have low habitual carbohydrate intake compared to the recommended guidelines 318 
of 6-10 g/kg/d (Thomas et al. 2016), it is possible that this may have influenced our results. 319 
Future research should look to implement standardised meals to ensure that optimal intake of 320 
macronutrients prior to exercise are met. Further, participants were permitted to maintain their 321 
habitual anthocyanin intake in an effort to increase the ecological validity of the findings. 322 
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However, it is possible that by increasing ecological validity we may have limited our ability to 323 
detect any meaningful benefit of NZBC extract supplementation on recovery.  324 
 325 
In conclusion, NZBC extract supplementation for 7-days prior to and 2-days following a half-326 
marathon, does not affect the recovery of muscle function, muscle soreness and fatigue or 327 
markers of inflammation in recreational half-marathon runners.  328 
 329 
Novelty statement 330 
 This is the first study where NZBC extract supplementation has been assessed for its 331 
potential as a recovery aid in an ecologically valid setting following half-marathon 332 
running in recreational runners. However, the present study suggests that NZBC 333 
supplementation has no effect on recovery of EIMD parameters in recreational runners 334 
following a half-marathon.   335 
 336 
Practical applications 337 
 NZBC did not improve the recovery of markers of EIMD following a half-marathon 338 
event, but no negative effects of supplementation were found.  339 
 Utilising CMJ neuromuscular variables provides greater insight and sensitivity into how 340 
participants may adopt a different CMJ strategy following half-marathon running, 341 
potentially highlighting aspects of relevance to real-world sporting performance that 342 
may be masked when only considering variables such as jump height.  343 
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Table 1 Descriptive data of the volunteer Half-Marathon runners in the NZBC and placebo 460 
groups 461 
Participant Characteristics  NZBC (n = 10) Placebo (n = 10) 
Age (years) 30 ± 4 29 ± 7 
Sex (M/F) 6/4 6/4 
Height (m) 1.72 ± 0.78 1.74 ± 0.67 
Body Mass (kg) 69.0 ± 8.1 68.0 ± 7.8 
Estimated female menstrual cycle phase 
Luteal  
Follicular 
 
3 
1 
 
2 
2 
Years running 6 ± 5 11 ± 5 
Average weekly mileage 12 ± 8 14 ± 7 
Longest training run (miles) 11 ± 6 11 ± 6 
Previous half-marathons 5 ± 3 6 ± 4 
Predicted finish time (h:min:s) 1:56:30 ± 0:15:40 1:58:18 ± 0:22:52 
Actual finish time (h:min:s) 1:58:12 ± 0:17:53 1:54:54 ± 0:18:15 
Average Heart Rate (bpm) 166 ± 16 162 ± 27 
Values are mean ± SD, n = 20.  462 
 463 
 464 
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 465 
Table 2 Absolute and relative to body mass average daily intake macronutrient intake prior to 466 
and for the 2-day following the half-marathon and habitual anthocyanin intake as indicated 467 
from the anthocyanin food frequency questionnaire (n = 10 per group, Mean ± SD). 468 
 469 
Nutritional component NZBC Placebo 
 
Total energy intake (kJ) 
(kJ⋅kg body mass-1) 
 
9091 ± 3319 
133 ± 46 
 
8903 ± 2198 
134 ± 38 
Carbohydrate (g) 
(g⋅kg body mass-1) 
226 ± 73  
3.3 ± 1.1 
249 ± 68 
3.8 ± 1.1 
Protein (g) 
(g⋅kg body mass-1) 
107 ± 37 
1.6 ± 0.5 
92 ± 23 
1.4 ± 0.4 
Fat (g) 
(g⋅kg body mass-1) 
93 ± 46 
1.3 ± 0.6 
84 ± 23 
1.3 ± 0.4 
Habitual anthocyanin intake (mg.day-1) 153 ± 122 172 ± 81 
 470 
  471 
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Table 3. Indices of muscle function and damage for both New Zealand blackcurrant and 472 
placebo groups before and following Half-Marathon race 473 
CMJ variable Pre Half-
Marathon 
Post Half-
Marathon 
24 h post Half-
Marathon 
48 h post Half-
Marathon 
Time to take off (s)# 
NZBC 
PLA 
PL 
 
0.96 ± 0.12 
0.93 ± 0.17 
 
1.03 ± 0.20 
0.98 ± 0.16 
 
0.95 ± 0.13 
1.02 ± 0.17 
 
0.91 ± 0.11 
1.03 ± 0.19 
Concentric phase peak force 
(N·kg)* 
NZBC 
PLA 
 
 
11.32 ± 1.56 
11.33 ± 3.34 
 
 
10.40 ± 1.72 
10.32 ± 2.07 
 
 
10.16 ± 2.02 
10.05 ± 2.04 
 
 
10.51 ± 1.99 
10.03 ± 2.27 
Concentric phase net impulse 
(Ns·kg)* 
NZBC 
PLA 
 
 
2.06 ± 0.36  
2.06 ± 0.33 
 
 
1.94 ± 0.28 
1.87 ± 0.28 
 
 
2.02 ± 0.32 
2.06 ± 0.25 
 
 
2.10 ± 0.31 
2.13 ± 0.27  
 
Concentric phase average 
power (W·kg)* 
NZBC 
PLA 
 
 
 
20.06 ± 4.31  
19.81 ± 4.03  
 
 
 
17.98 ± 3.35 
16.64 ± 3.29 
 
 
 
18.99 ± 4.04 
20.68 ± 6.56  
 
 
 
19.83 ± 3.66 
19.78 ± 4.39  
 
Concentric phase average 
duration (s) 
NZBC 
PLA 
 
 
 
0.32 ± 0.05  
0.33 ± 0.06 
 
 
 
0.32 ± 0.06 
0.33 ± 0.06 
 
 
 
0.33 ± 0.06 
0.34 ± 0.07 
 
 
 
0.32 ± 0.05 
0.33 ± 0.07 
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 474 
Values are mean ± SD, n = 10 per group. #Time*Supplement interaction (P=0.02). *Main effect of 475 
time but not statistically significant when Bonferroni correction applied (P>0.05). **Elevated above 476 
pre-half marathon at immediately post (time effect, P<0.05). ***Elevated above pre-half marathon 477 
immediately post, 24 and 48 h post (time effect, P<0.05) No other group or interaction effects 478 
observed (P>0.05). NZBC, New Zealand blackcurrant; PLA, placebo.  479 
  480 
 
Eccentric phase peak force 
(N·kg) 
NZBC 
PLA 
 
 
 
10.16 ± 2.16 
10.79 ± 3.56 
 
 
 
7.12 ± 1.14*** 
6.49 ± 1.30*** 
 
 
 
7.99 ± 1.41*** 
7.24 ± 1.73*** 
 
 
 
8.42 ± 1.68*** 
7.97 ± 2.56*** 
 
Eccentric phase net impulse 
(Ns·kg) 
NZBC 
PLA 
 
 
 
1.01 ± 0.26 
1.06 ± 0.20 
 
 
 
0.89 ± 0.20** 
0.77 ± 0.13** 
 
 
 
0.94 ± 0.23 
0.83 ± 0.16 
 
 
 
0.98 ± 0.20 
0.91 ± 0.15 
 
Eccentric phase displacement 
(braking phase) (m)* 
NZBC 
PLA 
 
 
 
0.21 ± 0.03 
0.30 ± 0.17 
 
 
 
0.26 ± 0.05 
0.29 ± 0.08 
 
 
 
0.24 ± 0.05 
0.27 ± 0.06 
 
 
 
0.23 ± 0.04 
0.30 ± 0.10 
 
Eccentric phase average 
duration (s)* 
NZBC 
PLA 
 
 
 
0.21 ± 0.03 
0.25 ± 0.06 
 
 
 
0.26 ± 0.05 
0.29 ± 0.08 
 
 
 
0.24 ± 0.05 
0.27 ± 0.06 
 
 
 
0.23 ± 0.04 
0.30 ± 0.10 
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Figure legends 481 
 482 
Figure 1. Study design. 483 
 484 
Figure 2a 2b, 3 a and 3b and 4 - 2a. Percentage change from pre half-marathon in 485 
countermovement jump (CMJ) height and post half-marathon (*pre to post; P < 0.01). 2b. 486 
Percentage change from pre half-marathon in reactive strength index modified (RSImod) and 487 
post half-marathon (*pre to post; P < 0.01). 3a. Muscle soreness ratings pre and post half-488 
marathon (*pre to post; P < 0.01). 3b. Muscle fatigue ratings pre and post half-marathon (*pre 489 
to post; P < 0.01). 4. Interleukin-6 urine concentrations with creatinine correction pre and post 490 
half-marathon (**pre to 48 h; P<0.01). Values are mean ± SD (n = 10 per group for 2a, 2b, 3a, 491 
3b and 4).  492 
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